The Weekly Litigation News Digest is now live. Subscribe now

IP Verse

Suppression Of Bone Cancer-Induced Allodynia - EP3796929

The patent EP3796929 was granted to Ipsen Biopharm on Sep 18, 2024. The application was originally filed on May 21, 2019 under application number EP19725358A. The patent is currently recorded with a legal status of "Granted And Under Opposition".

EP3796929

IPSEN BIOPHARM
Application Number
EP19725358A
Filing Date
May 21, 2019
Status
Granted And Under Opposition
Aug 15, 2024
Publication Date
Sep 18, 2024
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

MERZ PHARMAJun 18, 2025WALLINGER RICKER SCHLOTTER TOSTMANNADMISSIBLE

Patent Citations (20) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication Number
DESCRIPTIONUS2007166332
DESCRIPTIONUS5223409
DESCRIPTIONWO2007104567
DESCRIPTIONWO2008008803
DESCRIPTIONWO2008008805
DESCRIPTIONWO2011018665
DESCRIPTIONWO2011022357
DESCRIPTIONWO9206204
DESCRIPTIONWO9421300
DESCRIPTIONWO9633273
DESCRIPTIONWO9807864
DESCRIPTIONWO9932272
EXAMINATIONUS2013324535
INTERNATIONAL-SEARCH-REPORTUS2012230975
INTERNATIONAL-SEARCH-REPORTUS2014099294
INTERNATIONAL-SEARCH-REPORTUS6641820
OPPOSITIONUS2006275325
OPPOSITIONUS2013324535
OPPOSITIONUS6641820
OPPOSITIONWO2019224184

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents